MOBILE VIEW  | 

TYPHUS

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Typhus is the result of a rickettsial infection. Rickettsiae are gram-negative, nonmotile, small obligate intracellular coccobacilli that multiply in the cytoplasm of infected host cells. Three types of typhus may occur and include: epidemic typhus (Rickettsia prowazekii), endemic typhus (Rickettsia typhi) and scrub typhus (Rickettsia tsutsugamushi). Epidemic louse-borne typhus is frequently fatal, while endemic (or murine) typhus is rarely fatal.

Specific Substances

    1) Brill-Zinsser disease
    2) Chigger-borne typhus (scrub typhus)
    3) Endemic typhus
    4) Epidemic typhus
    5) Murine typhus (endemic typhus)
    6) Rickettsia mooseri
    7) Rickettsia prowazekii
    8) Rickettsia tsutsugamushi
    9) Rickettsia typhi
    10) Scrub typhus
    11) Squirrel-borne typhus
    12) Sylvatic typhus
    13) Tsutsugamushi disease (scrub typhus)
    14) RICKETTSIA PROWAZEKII (BIOLOGICAL WARFARE AGENT)
    15) TYPHUS (BIOLOGICAL WARFARE AGENT)

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) TOXICOLOGY: Typhus is the result of a rickettsial infection. Rickettsiae are gram-negative, nonmotile, small obligate intracellular coccobacilli that multiply in the cytoplasm of infected host cells. Three types of typhus may occur and include: EPIDEMIC TYPHUS (Rickettsia prowazekii), ENDEMIC TYPHUS (Rickettsia typhi) and SCRUB TYPHUS (Rickettsia tusutugamushi). Rickettsia organisms from the bloodstream enter small vessel endothelium (especially in the skin, brain, heart and kidneys) and cause cell destruction, endovasculitis, thrombosis, and hemorrhage (DIC).
    B) EPIDEMIOLOGY: EPIDEMIC TYPHUS: The only rickettsial disease that results in epidemics in humans, usually during periods of wars or famines. All ages and races and both sexes are affected. Geographic distribution is worldwide.
    1) ENDEMIC TYPHUS: All races are affected. More common in adults and males. Seasonal incidences are more common in summer and autumn, with 50 to 70 cases per year reported in the United States. Geographic distribution is worldwide. Highest prevalence is primarily in urban areas.
    2) SCRUB TYPHUS: All races and ages are affected. In Korea, it is more common in females. Geographic distribution is primarily in the Asian-Pacific region, ranging from northern Australia in the south to the far east of Russia in the north and Afghanistan in the west.
    3) SYLVATIC (SQUIRREL-BORNE) TYPHUS: Although strains of Rickettsia prowazekii associated with louse-borne typhus appear identical to strains associated with squirrel-borne typhus, there are minor differences. Incidences occur year round.
    C) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE TOXICITY: Fever and chills are common presenting symptoms. Rashes are typical: Epidemic typhus with maculopapular and petechial (trunk to extremities) rashes; murine typhus with macular and maculopapular rashes; and scrub typhus with macular and maculopapular (trunk and extremities) rashes with eschar. Nausea can occur in all types of typhus.
    2) SEVERE TOXICITY: Vasculitis is a hallmark of rickettsial infections. Rickettsia increase capillary permeability leading to intravascular coagulation, organ failure, and peripheral vascular collapse, the primary cause of shock and death. Thrombocytopenia has been observed as a severe complication in all types of typhus. Central nervous system complications (all types) may include neuropsychiatric abnormalities and seizures in addition to confusion, delirium, slurred speech, and nuchal rigidity. Respiratory failure and adult respiratory distress syndrome (ARDS) have been reported in complicated cases of typhus (all types).
    a) EPIDEMIC TYPHUS: Incubation period is 6 to 15 days. One to three days of malaise precedes an abrupt onset of severe headache, chills and fever, and myalgia. Rash and petechiae are characteristic. More serious complications may include gangrene and cerebral thrombosis. Laboratory findings may include thrombocytopenia and elevations of aspartate aminotransferase and lactate dehydrogenase. Death has been reported.
    b) ENDEMIC (MURINE) TYPHUS: After a 6 to 14 day incubation period, an abrupt onset of symptoms, including fever, followed by headache, chills, and nausea generally occurs. Rash may occur at various intervals after the onset of fever. Laboratory abnormalities may include leukopenia and thrombocytopenia, elevated liver function tests, hyponatremia, and hypocalcemia. Clinical course is usually uncomplicated and fatalities are rare.
    c) SCRUB TYPHUS: A skin papule develops within 2 days of the chigger feeding and progresses to an eschar during the 6 to 18 day incubation period. Onset of symptoms is abrupt, and includes unremitting fever, chills, and headache. Symptoms have included myalgia, cough, and nausea. Generalized lymphadenopathy is common. With no antibiotic therapy, many complications, including death, may occur.
    0.2.3) VITAL SIGNS
    A) WITH POISONING/EXPOSURE
    1) Chills and fever are commonly seen in all forms of typhus as presenting symptoms. Fever may be severe and persistent.
    0.2.4) HEENT
    A) WITH POISONING/EXPOSURE
    1) Tinnitus, conjunctivitis, papilledema and ophthalmoplegia have been reported in some typhus cases.
    0.2.20) REPRODUCTIVE
    A) Vertical transmission of scrub typhus through the placental barrier from mother to fetus has occurred.

Laboratory Monitoring

    A) Monitor hematologic parameters, including white blood cells, hematocrit, ESR, coagulation tests, and platelets.
    B) Monitor fluid and electrolyte status.
    C) Monitor renal and hepatic function tests.
    D) Monitor arterial blood gases for hypoxemia and metabolic acidosis in patients with severe illness.
    E) Confirmation of a typhus diagnosis is usually made serologically.
    F) Fluorescent antibody titer detects antibodies to specific antigens of R typhi, R prowazekii, or R tsutsugamushi.

Treatment Overview

    0.4.2) ORAL/PARENTERAL EXPOSURE
    A) Endemic typhus has been reported due to food contaminated with infected rat feces. It is possible that populations may be infected during biological warfare through contaminated foods. Treatment is the same as described in the BITES/STINGS Treatment section.
    0.4.3) INHALATION EXPOSURE
    A) Epidemic and endemic typhus may be developed as a biologic warfare agents and disseminated via inhalation routes. Treatment is the same as described in the BITES/STINGS Treatment section.
    0.4.5) DERMAL EXPOSURE
    A) OVERVIEW
    1) Dermal contact by accidental splashing of murine typhus organisms onto the lips and eyes has occurred in a laboratory microbiologist with resultant infection. Treatment is the same as described in the BITES/STINGS Treatment section.
    0.4.6) PARENTERAL EXPOSURE
    A) Needle stick exposure to scrub typhus has resulted in an active case of scrub typhus in a nurse caring for an infected patient. Treatment is the same as described in the BITES/STINGS Treatment section.
    0.4.7) BITES/STINGS
    A) MANAGEMENT OF MILD TO MODERATE TOXICITY
    1) Treatment is symptomatic and supportive. Monitor vital signs and mental status. FEVER: Treat with antipyretics. For temperatures greater than 38.9 degrees C, cooling measures such as a cooling blanket or tepid sponging should be considered. Monitor fluid balance and electrolyte status. ANTIBIOTIC THERAPY: Antibiotics are highly effective in the treatment of all types of typhus. Tetracyclines and chloramphenicol are the first drugs of choice. DOXYCYCLINE: 200 mg/day, orally, for 5 days in cases of epidemic typhus; continued for 7 to 15 days in cases of endemic typhus; and continued for 15 days in cases of scrub typhus. CHLORAMPHENICOL: Alternatively, chloramphenicol, 2 gm/day, orally, may be given. Intravenous antibiotics may be substituted. ALTERNATIVE THERAPY: Ciprofloxacin is reportedly effective and may be used as an alternative drug for treatment against rickettsial (endemic rickettsia) infection. CHEMOPROPHYLAXIS: For travelers at high risk for disease, chemoprophylaxis with weekly doses of doxycycline, 200 mg orally, can prevent scrub typhus and epidemic typhus. HYPOTENSION: Infuse 10 to 20 mL/kg isotonic fluids. PREVENTION: Prevention of endemic (murine) typhus is directed at control of the flea vector and mammalian reservoirs of infection.
    B) MANAGEMENT OF SEVERE TOXICITY
    1) Treatment is symptomatic and supportive. ANTIBIOTIC THERAPY: (Same as described above). Monitor for hypotension, respiratory depression, seizures and dysrhythmias. Administer isotonic fluids in patients with dehydration and shock. Patients may require vasopressors as well to maintain perfusion; dopamine and norepinephrine can be used initially. Treat acute lung injury with supportive care. Maintain ventilation and oxygenation and evaluate with frequent arterial blood gases and/or pulse oximetry monitoring. Early use of PEEP and mechanical ventilation may be needed. Treat seizures initially with benzodiazepines (ie, diazepam or lorazepam); propofol or phenobarbital are good second-line options if seizures recur after initial treatment.
    C) DECONTAMINATION
    1) GI decontamination is not indicated.
    D) DELOUSING
    1) Delousing is imperative in lice-infected patients with epidemic typhus since antibiotic therapy does not eradicate rickettsia in these individuals. For the treatment of head lice in children and adults, use permethrin.
    E) AIRWAY MANAGEMENT
    1) Administer oxygen to patients with hypoxia, respiratory depression or pulmonary edema. Intubation and mechanical ventilation may be necessary in severely ill patients and those with respiratory failure.
    F) ANTIDOTE
    1) None. A vaccine is no longer available in the United States.
    G) ACUTE LUNG INJURY
    1) Maintain ventilation and oxygenation and evaluate with frequent arterial blood gases and/or pulse oximetry monitoring. Early use of PEEP and mechanical ventilation may be needed.
    H) ENHANCED ELIMINATION
    1) Enhanced elimination is not anticipated to be necessary.
    I) PATIENT DISPOSITION
    1) HOME CRITERIA: Patients with early, mild illness may be treated on an outpatient basis with oral antibiotics if they are reliable and close follow-up observation can be arranged. Other family members should also be checked and monitored for illness especially in cases of scrub typhus (transmitted by chigger mites) and epidemic typhus (louse-borne typhus).
    2) OBSERVATION CRITERIA: Patients should be admitted.
    3) ADMISSION CRITERIA: Patients with suspected or confirmed typhus should be admitted. Patients that develop severe complications (ie, DIC, ARDS) may require an intensive care setting.
    4) CONSULT CRITERIA: Consider infectious disease, dermatology and or internal medicine consults for identification of rash. Consultation with a hematologist or pulmonologist may be indicated in patients that develop severe complications.
    5) TRANSFER CRITERIA: Transport is necessary when facilities for intensive care and invasive monitoring of the critically ill patient are not available.
    J) PITFALLS
    1) Typhus may appear as mild illness, but has the potential to cause severe illness.
    K) DIFFERENTIAL DIAGNOSIS
    1) Many patients that present with undifferentiated fever in tropical areas may be due to malaria, dengue fever, rickettsioses, leptospirosis and enteric fever and appear initially similar to scrub typhus. Septic patients should be covered broadly with antibiotics. A good history and identification of the rash may prove most beneficial for determining the etiology of the patient's illness.

Summary Of Exposure

    A) TOXICOLOGY: Typhus is the result of a rickettsial infection. Rickettsiae are gram-negative, nonmotile, small obligate intracellular coccobacilli that multiply in the cytoplasm of infected host cells. Three types of typhus may occur and include: EPIDEMIC TYPHUS (Rickettsia prowazekii), ENDEMIC TYPHUS (Rickettsia typhi) and SCRUB TYPHUS (Rickettsia tusutugamushi). Rickettsia organisms from the bloodstream enter small vessel endothelium (especially in the skin, brain, heart and kidneys) and cause cell destruction, endovasculitis, thrombosis, and hemorrhage (DIC).
    B) EPIDEMIOLOGY: EPIDEMIC TYPHUS: The only rickettsial disease that results in epidemics in humans, usually during periods of wars or famines. All ages and races and both sexes are affected. Geographic distribution is worldwide.
    1) ENDEMIC TYPHUS: All races are affected. More common in adults and males. Seasonal incidences are more common in summer and autumn, with 50 to 70 cases per year reported in the United States. Geographic distribution is worldwide. Highest prevalence is primarily in urban areas.
    2) SCRUB TYPHUS: All races and ages are affected. In Korea, it is more common in females. Geographic distribution is primarily in the Asian-Pacific region, ranging from northern Australia in the south to the far east of Russia in the north and Afghanistan in the west.
    3) SYLVATIC (SQUIRREL-BORNE) TYPHUS: Although strains of Rickettsia prowazekii associated with louse-borne typhus appear identical to strains associated with squirrel-borne typhus, there are minor differences. Incidences occur year round.
    C) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE TOXICITY: Fever and chills are common presenting symptoms. Rashes are typical: Epidemic typhus with maculopapular and petechial (trunk to extremities) rashes; murine typhus with macular and maculopapular rashes; and scrub typhus with macular and maculopapular (trunk and extremities) rashes with eschar. Nausea can occur in all types of typhus.
    2) SEVERE TOXICITY: Vasculitis is a hallmark of rickettsial infections. Rickettsia increase capillary permeability leading to intravascular coagulation, organ failure, and peripheral vascular collapse, the primary cause of shock and death. Thrombocytopenia has been observed as a severe complication in all types of typhus. Central nervous system complications (all types) may include neuropsychiatric abnormalities and seizures in addition to confusion, delirium, slurred speech, and nuchal rigidity. Respiratory failure and adult respiratory distress syndrome (ARDS) have been reported in complicated cases of typhus (all types).
    a) EPIDEMIC TYPHUS: Incubation period is 6 to 15 days. One to three days of malaise precedes an abrupt onset of severe headache, chills and fever, and myalgia. Rash and petechiae are characteristic. More serious complications may include gangrene and cerebral thrombosis. Laboratory findings may include thrombocytopenia and elevations of aspartate aminotransferase and lactate dehydrogenase. Death has been reported.
    b) ENDEMIC (MURINE) TYPHUS: After a 6 to 14 day incubation period, an abrupt onset of symptoms, including fever, followed by headache, chills, and nausea generally occurs. Rash may occur at various intervals after the onset of fever. Laboratory abnormalities may include leukopenia and thrombocytopenia, elevated liver function tests, hyponatremia, and hypocalcemia. Clinical course is usually uncomplicated and fatalities are rare.
    c) SCRUB TYPHUS: A skin papule develops within 2 days of the chigger feeding and progresses to an eschar during the 6 to 18 day incubation period. Onset of symptoms is abrupt, and includes unremitting fever, chills, and headache. Symptoms have included myalgia, cough, and nausea. Generalized lymphadenopathy is common. With no antibiotic therapy, many complications, including death, may occur.

Vital Signs

    3.3.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Chills and fever are commonly seen in all forms of typhus as presenting symptoms. Fever may be severe and persistent.
    3.3.3) TEMPERATURE
    A) WITH POISONING/EXPOSURE
    1) SUMMARY
    a) Chills and fever, seen in the abrupt onset of symptoms, is common to all forms of typhus (Jung et al, 2014; Woodward, 1994; Baxter, 1996; Perine et al, 1992; Yi et al, 1993; Bise & Coninx, 1997; Berman & Kundin, 1973; Lee et al, 1995; Loh et al, 1996; Marschang et al, 1995; Singh, 1994; Raoult et al, 1998).
    2) ENDEMIC TYPHUS
    a) INCIDENCE: In cases of endemic (murine) typhus, fever is the most common presenting symptom, occurring in up to 96% of cases. In a study of 87 American soldiers with scrub typhus, all were reported to have fever (Baxter, 1996). In another study of 60 patients with epidemic typhus, all were reported to have abrupt onset of chills and fever (Perine et al, 1992). In a retrospective study of 30 children diagnosed with murine typhus, 100% developed fever (Fergie et al, 2000).
    3) EPIDEMIC TYPHUS
    a) EPIDEMIC TYPHUS: Recent outbreaks were reported in Burundi and areas of Russia. Fever with severe headache and myalgias were the usual presenting symptoms (Raoult et al, 1998; Tarasevich et al, 1998). In another study of children with murine typhus, fever and headache or rash were also early findings of illness and reported in 90% (n=83) of cases
    4) SCRUB TYPHUS
    a) Acute undifferentiated fever is a common early finding of scrub typhus. However, it can be confused with many other diseases or illnesses in tropical areas including malaria, dengue fever, rickettsioses, leptospirosis, and enteric fever (Jung et al, 2014).
    3.3.4) BLOOD PRESSURE
    A) WITH POISONING/EXPOSURE
    1) Severe, untreated cases of typhus may present with decreased blood pressure (Woodward, 1994).

Heent

    3.4.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Tinnitus, conjunctivitis, papilledema and ophthalmoplegia have been reported in some typhus cases.
    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) Conjunctival suffusion and photophobia have been reported in typhus cases and is a diagnostic clue (Watt & Strickman, 1994; Perine et al, 1992). Conjunctivitis, with episcleral vessel dilation and subconjunctival hemorrhage, and retinal and papillary edema may occur in scrub typhus and is referred to as "scrub typhus retinopathy" (Boyd & Neldner, 1992; Kato et al, 1997).
    2) Papilledema and ophthalmoplegia have been reported in severe cases (Wenzel et al, 1986).
    3) Photophobia has been described in a case of murine typhus (Beaman & Marinovitch, 1999).
    3.4.4) EARS
    A) WITH POISONING/EXPOSURE
    1) Transient deafness and tinnitus, which may occur in up to one-third of scrub typhus patients, is a diagnostic clue (Watt & Strickman, 1994; Singh, 1994). Tinnitus was reported in 23% of epidemic typhus patients in one study (Perine et al, 1992).
    3.4.6) THROAT
    A) WITH POISONING/EXPOSURE
    1) A nonproductive cough and pharyngitis, or sore throat, are common early symptoms in all forms of typhus (Woodward, 1994; Perine et al, 1992; Berman & Kundin, 1973; Beaman & Marinovitch, 1999).

Cardiovascular

    3.5.2) CLINICAL EFFECTS
    A) VASCULITIS
    1) WITH POISONING/EXPOSURE
    a) In untreated and complicated cases of typhus, vasculitis, due to increased capillary permeability caused by the rickettsiae organism, may occur and progress to peripheral vascular collapse and shock (Baxter, 1996; Hornick, 1996; Wenzel et al, 1986; Pai et al, 1997; Watt & Strickman, 1994).
    B) SHOCK
    1) WITH POISONING/EXPOSURE
    a) Severe and/or untreated cases may result in vasculitis leading to shock and peripheral vascular collapse (Baxter, 1996; Hornick, 1996; Lee et al, 1995).
    b) SCRUB TYPHUS: In a study conducted in India, scrub typhus was diagnosed in 49 patients with nonspecific acute febrile illness. Of those 49 patients, severe complications included ARDS (n=28), acute kidney illness (n=26), shock (n=8) and death in 8 patients (Kumar et al, 2014).
    C) GANGRENOUS DISORDER
    1) WITH POISONING/EXPOSURE
    a) Gangrene, secondary to vasculitis and peripheral vascular collapse, is a serious complication of epidemic typhus. The gangrene is generally symmetric, affecting the distal fingers, toes, nose, and genitalia due to occlusion of arteries and veins over bony prominences and distally (Baxter, 1996; Boyd & Neldner, 1992).
    D) MYOCARDITIS
    1) WITH POISONING/EXPOSURE
    a) Myocarditis may occur, leading to conduction disturbances and heart failure in epidemic typhus. Interstitial myocarditis is more common in scrub typhus, while occurring less commonly in endemic typhus (Woodward, 1994). One case of heart failure was reported in a scrub typhus-infected soldier in Vietnam (Berman & Kundin, 1973).
    E) ELECTROCARDIOGRAM ABNORMAL
    1) WITH POISONING/EXPOSURE
    a) An inappropriate bradycardia may typically be seen in early epidemic typhus, followed by tachycardia later in the disease (Boyd & Neldner, 1992).

Respiratory

    3.6.2) CLINICAL EFFECTS
    A) RESPIRATORY FAILURE
    1) WITH POISONING/EXPOSURE
    a) Respiratory failure, a severe complication of the typhus group, has been reported (Baxter, 1996).
    B) ACUTE LUNG INJURY
    1) WITH POISONING/EXPOSURE
    a) SCRUB TYPHUS: In a study conducted in India, scrub typhus was diagnosed in 49 patients with nonspecific acute febrile illness. Of those 49 patients, severe complications included ARDS (n=28), acute kidney illness (n=26), shock (n=8) and death in 8 patients (Kumar et al, 2014).
    b) Adult respiratory distress syndrome (ARDS) has been reported as a severe complication of scrub typhus in a traveler returning from Thailand (Watt & Strickman, 1994) and in two other patients with scrub typhus, one of whom died due to multiple organ failure (Lee et al, 1995).
    C) PNEUMONIA
    1) WITH POISONING/EXPOSURE
    a) Pneumonia, with pleural effusions, may occur and be seen on chest radiograph (Oh et al, 2001; Dupon et al, 1992; Niang et al, 1999).
    b) CASE REPORTS
    1) Scrub typhus pneumonitis was confirmed in a laboratory worker following exposure to the organism Orientia tsutsugamushi. On the day of admission the patient had a fever (40 degrees Celsius), chest tightness, cough, and decreased breath sounds in the left lung. Chest x-ray showed interstitial infiltrates of the lower lobes and a CT of the chest revealed enlarged lymph nodes in the mediastinum, ground-glass opacity in both lower lung fields, and pleural effusion. Symptoms improved within three days with doxycycline therapy (Oh et al, 2001).
    2) Chan et al (1995) reported a case of interstitial pneumonitis, confirmed on open lung biopsy, and with delayed resolution, in an adult diagnosed with scrub typhus (Chan et al, 1995).
    3) A case of pneumonia, requiring mechanical ventilation, was reported in a nurse following a needle stick exposure to scrub typhus (Jee et al, 1996).
    4) Yang et al (1995) reported a case of bilateral diffuse alveolar infiltration on chest x-ray and right pleural effusion in an adult with scrub typhus (Yang et al, 1995).

Neurologic

    3.7.2) CLINICAL EFFECTS
    A) CEREBRAL THROMBOSIS
    1) WITH POISONING/EXPOSURE
    a) Secondary to vasculitis, cerebral thrombosis is a serious complication of epidemic typhus. Neurological deficits, due to cerebral thrombosis, may take 2 to 4 weeks to resolve, with residual deficits uncommon (Baxter, 1996). Acute febrile cerebral vasculitis and perivasculitis were found on brain biopsy samples and autopsy in 3 patients with confirmed typhus. In the most severe case, vascular lesions involved the brainstem and thalami (Wenzel et al, 1986).
    B) HEADACHE
    1) WITH POISONING/EXPOSURE
    a) An abrupt onset of headache is common in all forms of typhus. Following 1 to 3 days of malaise, abrupt onset of headache occurs with epidemic typhus (Perine et al, 1992). With endemic and scrub typhus, abrupt onset of headache occurs after an incubation period of 6 to 14 days (Baxter, 1996; Chien et al, 1995; Berman & Kundin, 1973; Wenzel et al, 1986; Marschang et al, 1995; Raoult et al, 1998). In a retrospective case series of 30 children diagnosed with murine typhus, 77% complained of headache (Fergie et al, 2000).
    b) INCIDENCE: Fever and headache were common presenting symptoms in pediatric patients diagnosed with murine typhus. In one study, 84% (65/77) of children 4 years of age and older reported headache (Whiteford et al, 2001).
    C) CENTRAL NERVOUS SYSTEM FINDING
    1) WITH POISONING/EXPOSURE
    a) Neuropsychiatric effects may occur in untreated scrub typhus patients and in complicated epidemic and endemic typhus. Effects may include encephalopathy with confusion, delirium, hallucinations, slurred speech, gait ataxia, nuchal rigidity, and cranial nerve dysfunction. Meningism and coma have been reported in complicated epidemic typhus (Baxter, 1996; Boyd & Neldner, 1992; Shaked, 1991; Berman & Kundin, 1973; Wenzel et al, 1986; Pai et al, 1997; Raoult et al, 1997; Singh, 1994). EEG readings may be abnormal, with diffuse slow waves (Wenzel et al, 1986).
    1) CASE REPORT: In a complicated case of endemic typhus, a global encephalopathy, with sixth nerve palsies, ophthalmoplegia, increased intracranial pressure, and cerebral vasculitis were reported. This patient was comatose and died 8 weeks after onset of the typhus. Another case reported by the same author died of fulminant cerebral edema with histopathologic evidence of widespread extravasation of plasma and fibrin (Wenzel et al, 1986).
    2) Mild CSF pleocytosis was reported in 12 (48%) of 25 scrub typhus patients; CSF protein level was increased (greater than 50 mg/dL) in 7 patients. The scrub typhus organism appears to invade the CSF (Pai et al, 1997).
    D) SEIZURE
    1) WITH POISONING/EXPOSURE
    a) Seizures have been reported in complicated cases of epidemic and endemic typhus and may occur in untreated cases of scrub typhus (Baxter, 1996; Wenzel et al, 1986; Raoult et al, 1997).

Gastrointestinal

    3.8.2) CLINICAL EFFECTS
    A) NAUSEA, VOMITING AND DIARRHEA
    1) WITH POISONING/EXPOSURE
    a) One of the more common initial clinical symptoms in the initial phases of typhus is nausea, occurring in 33% of endemic typhus patients and 28% of scrub typhus patients (Baxter, 1996). Berman & Kundin (1973) reported emesis in 23% of scrub typhus patients and diarrhea in 21% of scrub typhus patients in a study of 87 cases of American servicemen in Vietnam. Marschang et al (1995) reported a 36% incidence of diarrhea. Nausea, vomiting and diarrhea were reported in a 65-year-old man diagnosed with epidemic typhus (Niang et al, 1999).
    B) ABDOMINAL PAIN
    1) WITH POISONING/EXPOSURE
    a) Acute abdominal pain, accompanied by nausea and vomiting, may be a severe presenting symptom in typhus cases, but is generally uncommon in scrub typhus cases (Yang et al, 1995).

Hepatic

    3.9.2) CLINICAL EFFECTS
    A) LIVER ENZYMES ABNORMAL
    1) WITH POISONING/EXPOSURE
    a) Approximately 50% of scrub typhus, 90% of endemic typhus and most epidemic typhus patients have elevated serum aspartate aminotransferase levels. Most epidemic and endemic typhus patients also have increased lactate dehydrogenase serum levels. Elevated liver enzyme levels generally return to baseline within 14 days of initiating therapy (Baxter, 1996; Perine et al, 1992; Dumler & Walker, 1994; Loh et al, 1996; Silpapojakul et al, 1996). Hepatic dysfunction occurred in 36 out of 47 (77%) scrub typhus patients in one study (Yang et al, 1995a).
    b) CASE SERIES: In a retrospective series of 30 children with endemic murine typhus, 67% were reported to have elevated transaminase levels (Fergie et al, 2000).
    B) SPLENOMEGALY
    1) WITH POISONING/EXPOSURE
    a) In one study, 43% of scrub typhus patients experienced splenomegaly (Berman & Kundin, 1973) and in another study, 13% of epidemic typhus patients experienced splenomegaly (Perine et al, 1992). Hepatosplenomegaly is described in endemic typhus infected patients (O'Connor et al, 1996).
    C) TOXIC HEPATITIS
    1) WITH POISONING/EXPOSURE
    a) A case of granulomatous hepatitis has been reported in a patient with confirmed scrub typhus. Hepatic biochemical tests and liver biopsy confirmed acute hepatitis, which resolved soon after antibiotic treatment (Chien et al, 1995). Liver biopsies in 4 patients infected with endemic typhus revealed portal tract and sinusoidal infiltrates, cloudy swelling and necrosis of the hepatocytes and some pseudogranuloma formation (Silpapojakul et al, 1996).
    D) JAUNDICE
    1) WITH POISONING/EXPOSURE
    a) Jaundice has been reported following complicated courses of typhus (Baxter, 1996; Silpapojakul et al, 1996; Yang et al, 1995).

Genitourinary

    3.10.2) CLINICAL EFFECTS
    A) RENAL FAILURE SYNDROME
    1) WITH POISONING/EXPOSURE
    a) Mild renal insufficiency has been reported in approximately 22% of endemic typhus patients, and renal failure with hematuria and proteinuria may occur in complicated cases of scrub, epidemic, and endemic typhus (Baxter, 1996; Lee et al, 1995; Yang et al, 1995a). Five patients with murine typhus were reported to have renal impairment; the most severe cases had renal failure with multifocal perivascular interstitial nephritis (Shaked et al, 1994).
    1) Renal failure with severe hemolysis and hemoglobinuria, as well as persistently elevated serum transcobalamin II, was reported in a patient diagnosed with malaria and scrub typhus (Areekul et al, 1995). Acute renal failure and disseminated intravascular coagulation were reported in a patient with epidemic typhus (Niang et al, 1999).
    2) Renal failure was reported in a traveler returning from Thailand as a complication of untreated scrub typhus (Watt & Strickman, 1994).
    b) CASE REPORT/SCRUB TYPHUS: A 74-year-old man presented with a fever of 5 days duration along with headache, myalgia, and productive cough. Upon examination the patient was disoriented and irritable with a fever (38.8 degrees C) and hypotension (90/60 mm Hg). Pedal edema was also noted. Antibiotic therapy was initiated for probable sepsis. Laboratory studies were significant for severe thrombocytopenia (INR 1.6, platelet count 18 x 10(9)/L, aPTT prolongation 10 seconds, and D-dimer 400 ng/mL) and renal insufficiency (serum creatinine 2.6 mg/dL). By day 2, he developed a symmetrical purpuric rash found on the palms, soles of the feet, arms and legs which became black and necrotic within 48 hours. Further serological testing was performed. By day 4, a serology test was positive for scrub typhus. Doxycycline was initiated and other antibiotic therapies were discontinued. Systemic symptoms gradually improved and his skin lesions resolved without sequelae and the patient was discharged to home on day 7 (Jain et al, 2014).
    c) SCRUB TYPHUS: In a study conducted in India, it was found that 24% of patients that presented with unexplained febrile illness were diagnosed with scrub typhus. Renal abnormalities were observed in 84% of these patients with evidence of acute kidney illness (AKI) in 53%. Jaundice, oliguria, and mortality were more likely to occur in patients with AKI. It was suggested that all patients with unexplained febrile illness be investigated for scrub typhus and of those that are diagnosed be monitored for the potential development of AKI (Kumar et al, 2014).
    B) GLOMERULONEPHRITIS
    1) WITH POISONING/EXPOSURE
    a) Patients with epidemic typhus may experience acute glomerulonephritis with hematuria due to rickettsial damage to the kidney (Woodward, 1994).

Acid-Base

    3.11.2) CLINICAL EFFECTS
    A) ACIDOSIS
    1) WITH POISONING/EXPOSURE
    a) Metabolic acidosis may occur in patients with severe typhus due to low oxygen utilization by peripheral tissue and poor oxygen exchange resulting from rickettsial damage to lung and vasculature (Baxter, 1996).

Hematologic

    3.13.2) CLINICAL EFFECTS
    A) LYMPHOCYTOSIS
    1) WITH POISONING/EXPOSURE
    a) A normal white blood cell count is typical in scrub typhus, with a lymphocytosis in most patients. An atypical appearance of the lymphocyte is expected (Baxter, 1996; Chien et al, 1995; Berman & Kundin, 1973).
    B) LEUKOPENIA
    1) WITH POISONING/EXPOSURE
    a) Mild leukopenia may initially occur in a minority of endemic typhus patients (Baxter, 1996; O'Connor et al, 1996) and in a minority of scrub typhus patients ((Ghorbani et al, 1997; Yang et al, 1995a). In a retrospective case series involving 30 children diagnosed with murine typhus, 40% developed leukopenia (Fergie et al, 2000).
    C) THROMBOCYTOPENIC DISORDER
    1) WITH POISONING/EXPOSURE
    a) SUMMARY: Thrombocytopenia may occur in a minority of endemic typhus patients (Loh et al, 1996; O'Connor et al, 1996), in approximately 40% of epidemic typhus patients (Baxter, 1996), and in scrub typhus patients (Jain et al, 2014; Ghorbani et al, 1997; Yang et al, 1995a; Beaman & Marinovitch, 1999).
    b) SCRUB TYPHUS: Hematologic abnormalities that have been observed with scrub typhus include thrombocytopenia, leucocytosis, and severe anemia (Kumar et al, 2014).
    c) CASE REPORT/EPIDEMIC TYPHUS: Niang et al (1999) described a patient with epidemic typhus and severe thrombocytopenia (4,900 thrombocytes/mm(3)) and Zanetti et al (1998) described another patient with a platelet count of 16 x 10(9)/L (Niang et al, 1999; Zanetti et al, 1998).
    d) CASE REPORT/SCRUB TYPHUS: A 74-year-old man presented with a fever of 5 days duration along with headache, myalgia, and productive cough. Upon examination the patient was disoriented and irritable with a fever (38.8 degrees C) and hypotension (90/60 mm Hg). Pedal edema was also noted. Antibiotic therapy was initiated for probable sepsis. Laboratory studies were significant for severe thrombocytopenia (INR 1.6, platelet count 18 x 10(9)/L, aPTT prolongation 10 seconds, and D-dimer 400 ng/mL) and renal insufficiency. By day 2, he developed a symmetrical purpuric rash found on the palms, soles of the feet, arms and legs which became black and necrotic within 48 hours. Further serological testing was performed. By day 4, a serology test was positive for scrub typhus. Doxycycline was initiated and other antibiotic therapies were discontinued. Systemic symptoms gradually improved and his skin lesions resolved without sequelae and the patient was discharged to home on day 7 (Jain et al, 2014).
    D) DISSEMINATED INTRAVASCULAR COAGULATION
    1) WITH POISONING/EXPOSURE
    a) Untreated and complicated typhus may progress to disseminated intravascular coagulation and death (Yi et al, 1993; Lee et al, 1995; Loh et al, 1996; Niang et al, 1999).
    E) ANEMIA
    1) WITH POISONING/EXPOSURE
    a) SCRUB TYPHUS: Hematologic abnormalities that have been observed with scrub typhus include thrombocytopenia, leucocytosis, and severe anemia (Kumar et al, 2014).
    F) ESR RAISED
    1) WITH POISONING/EXPOSURE
    a) The erythrocyte sedimentation rate (ESR) may be increased in typhus infections (Marschang et al, 1995).
    b) CASE REPORTS: Loh et al (1996) reported an ESR of 53 mm/hr and 46 mm/hr in two endemic typhus infected patients, respectively (Loh et al, 1996).
    c) CASE SERIES: An elevated ESR was reported in 75% of children (n=30) in a retrospective case series of patients diagnosed with murine typhus (Fergie et al, 2000).
    G) HEMOPHAGOCYTIC SYNDROME
    1) WITH POISONING/EXPOSURE
    a) HEMOPHAGOCYTIC SYNDROME has been described in a scrub typhus patient based on cytologic findings of many histiocytes containing phagocytosed blood cells in marrow aspirate. The patient recovered following antibiotic therapy (Chen et al, 2000).

Dermatologic

    3.14.2) CLINICAL EFFECTS
    A) ERUPTION
    1) WITH POISONING/EXPOSURE
    a) EPIDEMIC TYPHUS
    1) A maculopapular and petechial rash is most typical in epidemic typhus, with the rash being most evident on the trunk but also seen on the extremities. Rash may not always be evident (Zanetti et al, 1998). Petechiae may be seen on the conjunctival and soft palate. The rash typically begins in the axillary folds and upper trunk on the fifth day of illness and spreads to the extremities. Initially, the rash appears as non-confluent erythematous macules that blanch on pressure. The rash becomes maculopapular and petechial, affecting trunk and extremities, but sparing the face, palms, and soles (Baxter, 1996). Groen et al (1999) reported a patient with a macular-papular rash that evolved into an ulcer with a black necrotic eschar on the foot.
    b) ENDEMIC TYPHUS
    1) Macular and maculopapular rashes may be seen in cases of endemic (murine) typhus. Only 18% of patients will demonstrate a rash at presentation, however, 54% to 63% will develop rashes over the course of the illness. Median onset of the rash is 6 days, with a range of up to 18 days. Absence of a rash should not dissuade the clinician from a diagnosis of murine typhus. Appearance of the rash has been described as macular (in 49%), maculopapular (29%), papular (14%), petechial (6%), and morbilliform (3%). The rash spreads from trunk to extremities and vice versa equally, with rare involvement of the palms (Baxter, 1996; O'Connor et al, 1996). In a retrospective case series of 30 children diagnosed with murine typhus, 80% experienced rash (Fergie et al, 2000).
    2) INCIDENCE/CHARACTERISTICS: In a retrospective case series of pediatric patients diagnosed with murine typhus in Texas from 1979 to 1996, 59 (63%) of 94 patients developed a rash during the course of their illness (median time to onset was 6 days). A triad of symptoms including fever, headache and rash was present in 43 (49%) of 87 children. The characteristics of the rash found in 94 exposures were: macular (24/48) 50%, maculopapular (12/48) 25%, erythematous (5/48) 10%, petechial and macular (3/48) 6%, papular (2/48) 4%, and petechial (2/48) 4% (Whiteford et al, 2001).
    c) SCRUB TYPHUS
    1) Macular and maculopapular rashes generally appear within 2 days after the chigger feeds and progresses to an eschar at the site of inoculation during a 6 to 18 day incubation period. An eschar appearing at the site of a mite bite is pathognomonic (Dupon et al, 1992) (Yi et al. 1993) (Kato et al, 1997). An ulcer may occur at the eschar site (Ghorbani et al, 1997). The rash, when present, typically spreads from the trunk to the extremities, and begins as a macular eruption which may become papular.
    a) Adenopathies of scrub typhus may be more common than either eschar or rash, and are usually palpable, ranging from small kernels to large spongy glands (Berman & Kundin, 1973; Baxter, 1996). Generally, only those that drain the eschar are tender or suppurative (Baxter, 1996). Eschars are generally found near tender lymph nodes when present (Yi et al, 1993; Chien et al, 1995).
    b) A case of scrub typhus, transmitted by a needle stick to a nurse during the care of a scrub typhus patient, is reported. Erythematous swelling developed at the tip of her finger, the site of the needle stick, 7 days later. Ten days after the needle stick, fever and headache developed, and her skin lesion became vesicular. A rising indirect immunofluorescent antibody titer gave a positive diagnosis for scrub typhus, which improved following therapy with doxycycline (Jee et al, 1996).
    B) PURPURA FULMINANS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 74-year-old man presented with a fever of 5 days duration along with headache, myalgia, and productive cough. Upon examination the patient was disoriented and irritable with a fever (38.8 degrees C) and hypotension (90/60 mm Hg). Pedal edema was also noted. Antibiotic therapy was initiated for probable sepsis. Laboratory studies were significant for severe thrombocytopenia (INR 1.6, platelet count 18 x 10(9)/L, aPTT prolongation 10 seconds, and D-dimer 400 ng/mL) and renal insufficiency. By day 2, he developed a symmetrical purpuric rash found on the palms, soles of the feet, arms and legs which became black and necrotic within 48 hours. Further serological testing was performed. By day 4, a serology test was positive for scrub typhus. Doxycycline was initiated and other antibiotic therapies were discontinued. Systemic symptoms gradually improved and his skin lesions resolved without sequelae and the patient was discharged to home on day 7 (Jain et al, 2014).

Musculoskeletal

    3.15.2) CLINICAL EFFECTS
    A) MUSCLE PAIN
    1) WITH POISONING/EXPOSURE
    a) Abrupt onset of painful myalgias and arthralgias are common following 1 to 3 days of malaise in epidemic, endemic, and scrub typhus (Whiteford et al, 2001; Perine et al, 1992; Dupon et al, 1992; Yi et al, 1993; Ghorbani et al, 1997; Marschang et al, 1995; Raoult et al, 1998). Up to 32% of scrub typhus patients in one study developed myalgia (Berman & Kundin, 1973).

Immunologic

    3.19.2) CLINICAL EFFECTS
    A) LYMPHADENOPATHY
    1) WITH POISONING/EXPOSURE
    a) Generalized lymphadenopathy is the most common physical finding (approximately 85% of cases) in scrub typhus. Scrub typhus adenopathy is easily palpable, with nodes ranging from small kernels to large spongy glands. Generally, only those that drain the eschar are tender or suppurative (Baxter, 1996; Yi et al, 1993; Chien et al, 1995; Kato et al, 1997; Marschang et al, 1995).

Reproductive

    3.20.1) SUMMARY
    A) Vertical transmission of scrub typhus through the placental barrier from mother to fetus has occurred.
    3.20.2) TERATOGENICITY
    A) CONGENITAL ANOMALY
    1) A male neonate (2,200 grams) was delivered by cesarean section from a 34-week pregnant female with diagnosed scrub typhus. The infant was found to have hepatosplenomegaly and a positive scrub typhus IgM test. His condition deteriorated, with development of anemia, sepsis, and DIC. Treatment with chloramphenicol was begun. He recovered after one month. Residual effects included mildly retarded growth, microcephaly and encephalomalacia, which was seen on CT brain scan (Suntharasaj et al, 1997).
    3.20.3) EFFECTS IN PREGNANCY
    A) PLACENTAL BARRIER
    1) Vertical transmission of scrub typhus through the placental barrier from mother to fetus is reported in a 34-week pregnant female. The diagnosis was confirmed by positive Weil-Felix (OXK titer 1:320) and scrub typhus (titer 1:1600) tests in the mother; vertical transmission was demonstrated by positive scrub typhus IgM in the child. After cesarean section and following 7 days of antibiotic therapy, the mother recovered and was discharged (Suntharasaj et al, 1997).

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) Monitor hematologic parameters, including white blood cells, hematocrit, ESR, coagulation tests, and platelets.
    B) Monitor fluid and electrolyte status.
    C) Monitor renal and hepatic function tests.
    D) Monitor arterial blood gases for hypoxemia and metabolic acidosis in patients with severe illness.
    E) Confirmation of a typhus diagnosis is usually made serologically.
    F) Fluorescent antibody titer detects antibodies to specific antigens of R typhi, R prowazekii, or R tsutsugamushi.
    4.1.2) SERUM/BLOOD
    A) HEMATOLOGIC
    1) White blood cells are typically normal, but differential is shifted toward myelocytic series (Woodward, 1994).
    2) Hematocrit is generally normal, but normochromic anemia occurs in severe disease (Woodward, 1994).
    3) Erythrocyte sedimentation rate (ESR) may be increased (Marschang et al, 1995).
    4) Thrombocytopenia is characteristic due to consumption of platelets from numerous foci of endothelial injury in rickettsiosis (Boyd & Neldner, 1992).
    B) ACID/BASE
    1) Monitor arterial blood gases for hypoxemia and metabolic acidosis in severely symptomatic patients.
    C) BLOOD/SERUM CHEMISTRY
    1) Monitor serum electrolytes, particularly sodium and calcium, which may be decreased in patients with symptomatic typhus.
    2) Monitor renal function tests.
    3) Monitor liver function tests for elevated hepatic enzyme levels and increased creatine phosphokinase.
    4) Serum albumin may be decreased due to vascular permeability from damage to vasculature.
    4.1.3) URINE
    A) URINALYSIS
    1) Monitor for hematuria, particularly in patients with epidemic typhus, which may be indicative of rickettsial damage to the kidney causing acute glomerulonephritis (Woodward, 1994).
    4.1.4) OTHER
    A) OTHER
    1) CULTURES
    a) Isolation of the organism with culture is possible but hazardous. This requires specialized facilities and experienced personnel. Macrophages from blood may be cultured and then stained, but the test is not routinely available (Woodward, 1994).
    b) Rickettsia are not readily seen with ordinary light microscope. Stains poorly with Gram stain; stains well with Giminez, Giemsa, Macchiavello, and Castaneda stains (Woodward, 1994).
    2) TISSUE
    a) Biopsies of involved skin with direct fluorescent staining may be used. Disadvantages include little or no skin involvement or involvement too late in the course of the disease (Woodward, 1994).
    3) OXYGEN SATURATION
    a) Oxygen saturation should be monitored in severely symptomatic patients.
    4) ECG
    a) ECG monitoring is recommended in symptomatic typhus patients. Myocarditis may occur, leading to conduction disturbances and heart failure (Woodward, 1994).

Radiographic Studies

    A) CHEST RADIOGRAPH
    1) Chest x-ray should be performed on all symptomatic patients. Findings may reveal pulmonary infiltrates associated with rickettsial infection or pulmonary microcirculation, interstitial pneumonia, diffuse alveolar damage, and increased vascular permeability in the lungs (Woodward, 1994).

Methods

    A) IMMUNOASSAY
    1) A fluorescent antibody titer detects antibodies to specific antigens of R typhi, R prowazekii, or R tsutsugamushi. It is the current gold standard, the preferred diagnostic method, and the most common. It is also simple, rapid, and specific. Sera giving fluorescence at 1:40 dilution is considered positive (Botros et al, 1989; Yi et al, 1993; Woodward, 1994). Obtain blood prior to starting antimicrobial therapy (Woodward, 1994).
    a) Antibody titers can be used to differentiate murine typhus or scrub typhus from primary louse-borne typhus (Woodward, 1994). The Weil-Felix reaction may commonly be used in the diagnosis of murine or scrub typhus (Loh et al, 1996; Silpapojakul et al, 1995; McCalmont & Zanolli, 1989).
    b) Indirect fluorescent antibody (IFA) or complement fixation antibody concentrations peak at similar or slightly later times. A fourfold increase in titer between acute and convalescent serum specimens is diagnostic of typhus. A titer of 1:128 is considered diagnostic (Walker et al, 1989; Botros et al, 1989; Chien et al, 1995; Silpapojakul et al, 1995).
    2) Enzyme-linked immunosorbent assay (ELISA) is a common serologic test which detects both IgM and IgG and may be positive by the seventh day of illness. This method may provide a definitive diagnosis (Bise & Coninx, 1997; Raoult et al, 1997; Silpapojakul et al, 1995). If antimicrobials are used early in the disease, the test may be positive when others are not (Woodward, 1994).
    3) Polymerase chain reaction (PCR) assay is used to detect endemic, epidemic, and scrub typhus rickettsiae. It is sensitive and can detect even few rickettsiae in the blood. It also detects Rocky Mountain spotted fever rickettsiae but not other rickettsiae. This test is rapid, approximately 48 hours (Carl et al, 1990; Sugita et al, 1993).
    a) It achieves a rapid diagnosis of rickettsioses by amplification of specific rickettsial genes derived from the DNA of rickettsiae present in peripheral blood. The Rickettsial Disease Division of the Centers for Disease Control (CDC) in Atlanta, Georgia, has performed this test for the diagnosis of RMSF and human ehrlichiosis (Dumler & Walker, 1994).
    4) Concurrent infection with murine typhus and scrub typhus was diagnosed with PCR and indirect fluorescent antibody (IFA) in several patients (Phommasone et al, 2013).
    5) Dot blot immunoassay for rapid diagnosis of scrub typhus is described by Watt et al (1998). Two different antigen concentrations were used in a dot blot immunoassay. Lower concentrations coated on dipsticks lacked sensitivity when compared with an indirect immunoperoxidase test. When the antigen concentration on the dipstick was increased, sensitivity increased from 67% to 100%. The authors suggest that scrub typhus can be confirmed serologically using a dipstick assay, with serodiagnosis tailored to a target population.

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.6) DISPOSITION/BITE-STING EXPOSURE
    6.3.6.1) ADMISSION CRITERIA/BITE-STING
    A) Patients with suspected or confirmed typhus should be admitted. Patients that develop severe complications (ie, DIC, ARDS) may require an intensive care setting.
    6.3.6.2) HOME CRITERIA/BITE-STING
    A) Patients with early, mild illness may be treated on an outpatient basis with oral antibiotics if they are reliable and close follow-up observation can be arranged. Other family members should also be checked and monitored for illness especially in cases of scrub typhus (transmitted by chigger mites) and epidemic typhus (louse-borne typhus).
    6.3.6.3) CONSULT CRITERIA/BITE-STING
    A) Consider infectious disease, dermatology and or internal medicine consults for identification of rash. Consultation with a hematologist or pulmonologist may be indicated in patients that develop severe complications.
    6.3.6.4) PATIENT TRANSFER/BITE-STING
    A) Transport is necessary when facilities for intensive care and invasive monitoring of the critically ill patient are not available.
    6.3.6.5) OBSERVATION CRITERIA/BITE-STING
    A) Patients should be admitted.

Monitoring

    A) Monitor hematologic parameters, including white blood cells, hematocrit, ESR, coagulation tests, and platelets.
    B) Monitor fluid and electrolyte status.
    C) Monitor renal and hepatic function tests.
    D) Monitor arterial blood gases for hypoxemia and metabolic acidosis in patients with severe illness.
    E) Confirmation of a typhus diagnosis is usually made serologically.
    F) Fluorescent antibody titer detects antibodies to specific antigens of R typhi, R prowazekii, or R tsutsugamushi.

Oral Exposure

    6.5.1) PREVENTION OF ABSORPTION/PREHOSPITAL
    A) GI decontamination is not indicated. However, delousing is imperative in lice-infected patients with epidemic typhus since antibiotic therapy does not eradicate rickettsia in these individuals. Permethrin should be used to the treatment of head lice in adults and children.

Dermal Exposure

    6.9.1) DECONTAMINATION
    A) DERMAL DECONTAMINATION
    1) DECONTAMINATION: Remove contaminated clothing and wash exposed area thoroughly with soap and water for 10 to 15 minutes. A physician may need to examine the area if irritation or pain persists (Burgess et al, 1999).

Case Reports

    A) ADULT
    1) SCRUB TYPHUS
    a) A 30-year-old woman contracted scrub typhus via an infected mite bite while traveling in Thailand. On day 1 she reported an erythematous lesion on her left breast. On day 4 she reported fever (40 degrees C), fatigue, headache and diffuse myalgia. On day 5 she was admitted to the hospital due to persistent symptoms. A 1 cm black eschar was seen on the left breast with lymphadenopathy and several erythematous maculae on her upper thighs. A dry cough was present. Laboratory report included hemoglobin value of 10.5 grams/dL, WBC count of 2.76 x 10(9)/L, and elevated serum hepatic enzyme levels. An ECG revealed negative T-waves on inferior standard leads. Chest x-ray was positive for moderate interstitial pneumonia with small bilateral basal pleural effusions. Ampicillin therapy was ineffective. On day 15, diagnosis was confirmed by specific serology, with elevated titers (1/40) to Rickettsia tsutsugamushi antigens. Resolution occurred following 14 days of doxycycline therapy. Pulmonary symptoms resolved over 8 days and the eschar healed over 15 days. Two weeks after antibiotic therapy, a complete resolution of scrub typhus was evident (Dupon et al, 1992).
    2) ENDEMIC TYPHUS
    a) A 59-year-old man was admitted to the hospital with a 3 day history of chills and fever, myalgias, abdominal pain, and fatigue. Confusion and diffuse hypertonicity developed. Shortly after admission, intubation for airway protection due to recurrent seizures was started. Multiple occlusions of small branch retinal veins and arteries with secondary retinal hemorrhages were seen on funduscopic examination. Neurologic examination revealed nuchal rigidity, left gaze preference, and presence of bilateral Babinski signs. Technetium brain scan revealed diffuse isotope uptake and an EEG showed diffuse theta-wave slowing with some bilateral, anteriorly predominant sharp waves. Lumbar puncture demonstrated an opening pressure of 260 mm H2O; glucose, 106 mg/dL; protein, 272 mg/dL; leukocytes, 22/mm(3) with 70% lymphocytes; and erythrocytes, 37/mm(3). Empiric therapy with ampicillin, chloramphenicol, gentamicin, nafcillin, and vidarabine was begun. A bilateral petechial rash developed 4 days after onset of symptoms. Bilateral sixth nerve palsies and intranuclear ophthalmoplegia developed. Brain biopsy revealed vasculitis. High-dose dexamethasone was started, with no clinical improvement. Rickettsia rickettsii and Rickettsia typhi were both positive (1:512) in serum latex agglutination tests. After remaining comatose for 8 weeks, the patient died (Wenzel et al, 1986).

Toxicologic Mechanism

    A) VASCULITIS - Rickettsia organisms from the bloodstream enter small vessel endothelium (especially in the skin, brain, heart and kidneys) and cause cell destruction, endovasculitis, thrombosis, and hemorrhage (DIC). This results in vascular skin lesions, interstitial pneumonitis, myocardial infiltration (myocarditis), and panencephalitis; occlusion of multiple small vessels may infarct tissues causing distal gangrene (Woodward, 1994).
    1) Typhus nodules in the brain, with an inflammatory response and major role of the immune system, occur most frequently in midbrain and nuclear areas, which explains the frequent occurrence of neurological symptomatology in typhus infections. Prominent microvascular lesions of the brainstem have been shown at necropsy in patients with murine and scrub typhus (Shaked, 1991).
    B) CSF PERMEABILITY - Pai et al (1997) have speculated that scrub typhus organisms (Orientia tsutsugamushi), which are obligatory intracellular organisms, either enter the CSF in a monocyte or grow through the endothelium, by entering via the luminal cell membrane, replicating in the capillary endothelial cytoplasm, and released via the basal cell membranes into the perivascular space.

General Bibliography

    1) AMA Department of DrugsAMA Department of Drugs: AMA Evaluations Subscription, American Medical Association, Chicago, IL, 1992.
    2) Areekul S, Cheeramakara C, & Churdchu K: Persistently elevated serum transcobalamin II in a patient with cerebral malaria and typhus infections. J Med Assoc Thailand 1995; 78:48-52.
    3) Artigas A, Bernard GR, Carlet J, et al: The American-European consensus conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling.. Am J Respir Crit Care Med 1998; 157:1332-1347.
    4) Baxter JD: The typhus group. Clinics in Dermatol 1996; 14:271-278.
    5) Beaman MH & Marinovitch N: Murine typhus in metropolitan Perth (letter). Med J Aust 1999; 170:93-94.
    6) Berman SJ & Kundin WD: Scrub typhus in South Vietnam, a study of 87 cases. Ann Intern Med 1973; 79:26-30.
    7) Bise G & Coninx R: Epidemic typhus in a prison in Burundi. Trans Roy Soc Trop Med Hyg 1997; 91:133-134.
    8) Botros BAM, Soliman AK, & Darwish M: Seroprevalence of murine typhus and fievre boutonneuse in certain human populations in Egypt. J Trop Med Hyg 1989; 92:373-378.
    9) Boyd AS & Neldner KH: Typhus disease group. Intl J Dermatol 1992; 31:823-832.
    10) Brophy GM, Bell R, Claassen J, et al: Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17(1):3-23.
    11) Brower RG, Matthay AM, & Morris A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Eng J Med 2000; 342:1301-1308.
    12) Burgess JL, Kirk M, Borron SW, et al: Emergency department hazardous materials protocol for contaminated patients. Ann Emerg Med 1999; 34(2):205-212.
    13) Carl M, Tibbs CW, & Dobson ME: Diagnosis of acute typhus infection using the polymerase chain reaction. J Infect Dis 1990; 161:791-793.
    14) Cataletto M: Respiratory Distress Syndrome, Acute(ARDS). In: Domino FJ, ed. The 5-Minute Clinical Consult 2012, 20th ed. Lippincott Williams & Wilkins, Philadelphia, PA, 2012.
    15) Chamberlain JM, Altieri MA, & Futterman C: A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Ped Emerg Care 1997; 13:92-94.
    16) Chan CHS, Lai F, & Daly B: Scrub typhus pneumonitis with delayed resolution. J Trop Med Hyg 1995; 98:114-116.
    17) Chaniotis B, Psarulaki A, & Chaliotis G: Transmission cycle of murine typhus in Greece. Ann Trop Med Parasitol 1994; 88:645-647.
    18) Chen YC, Chao TY, & Lin JC: Scrub typhus-associated hemophagocytic syndrome. Infection 2000; 28:178-179.
    19) Chien RN, Liu NJ, & Lin PY: Granulomatous hepatitis associated with scrub typhus. J Gastroenterol Hepatol 1995; 10:484-487.
    20) Chin RF , Neville BG , Peckham C , et al: Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study. Lancet Neurol 2008; 7(8):696-703.
    21) Choonara IA & Rane A: Therapeutic drug monitoring of anticonvulsants state of the art. Clin Pharmacokinet 1990; 18:318-328.
    22) Dumler JS & Walker DH: Diagnostic tests for rocky mountain spotted fever and other rickettsial diseases. Dermatol Clin 1994; 12:25-36.
    23) Dupon M, Rogues AM, & Malou M: Scrub typhus: an imported rickettsial disease. Infection 1992; 20:153-154.
    24) Fergie JE, Purcell K, & Wanat D: Murine typhus in South Texas children Pediatr Infect Dis J 2000; 19:535-538.
    25) Ghorbani RP, Ghorbani AJ, Jain MK, et al: A case of scrub typhus probably acquired in Africa.. Clin Infect Dis 1997; 25:1473-1474.
    26) Haas CF: Mechanical ventilation with lung protective strategies: what works?. Crit Care Clin 2011; 27(3):469-486.
    27) Heap BJ: Scrub typhus in Hong Kong. J Trop Med Hyg 1991; 94:97-101.
    28) Hegenbarth MA & American Academy of Pediatrics Committee on Drugs: Preparing for pediatric emergencies: drugs to consider. Pediatrics 2008; 121(2):433-443.
    29) Hornick RB: Rickettsial diseases. In: Bennett JC & Plum F (Eds): Cecil Textbook of Medicine, 20'th ed, WB Saunders Company, Philadelphia, PA, 1996, pp 1726-1738.
    30) Hvidberg EF & Dam M: Clinical pharmacokinetics of anticonvulsants. Clin Pharmacokinet 1976; 1:161.
    31) Jain D, Viswanathan S, & Ramasamy C: A life threatening rash, an unexpected cause. Case Rep Dermatol Med 2014; 2014:146251.
    32) Jee HG, Chung MH, & Lee SG: Transmission of scrub typhus by needlestick from a patient receiving pefloxacin. Scand J Infect Dis 1996; 28:411-412.
    33) Jung HC, Chon SB, Oh WS, et al: Etiologies of Acute Undifferentiated Fever and Clinical Prediction of Scrub Typhus in a Non-Tropical Endemic Area. Am J Trop Med Hyg 2014; Epub:Epub.
    34) Kato T, Watanabe K, & Katori M: Conjunctival injection, episcleral vessel dilation, and subconjunctival hemorrhage in patients with new tsutsugamushi disease. Jpn J Ophthalmol 1997; 41:196-199.
    35) Kleinman ME, Chameides L, Schexnayder SM, et al: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 14: pediatric advanced life support. Circulation 2010; 122(18 Suppl.3):S876-S908.
    36) Kollef MH & Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995; 332:27-37.
    37) Kumar V, Kumar V, Yadav AK, et al: Scrub typhus is an under-recognized cause of acute febrile illness with acute kidney injury in India. PLoS Negl Trop Dis 2014; 8(1):e2605.
    38) Lee WS, Wang FD, & Wand LS: Scrub typhus complicating acute respiratory distress syndrome: A report of two cases. Chin Med J (Taipei) 1995; 56:205-210.
    39) Loddenkemper T & Goodkin HP: Treatment of Pediatric Status Epilepticus. Curr Treat Options Neurol 2011; Epub:Epub.
    40) Loh KC, Leo YS, & Heng MK: Murine typhus: A forgotten cause of febrile illness in Singapore. Singapore Med J 1996; 37:39-43.
    41) Manno EM: New management strategies in the treatment of status epilepticus. Mayo Clin Proc 2003; 78(4):508-518.
    42) Marschang A, Nothdurft HD, & Kumlien S: Imported rickettsioses in German travelers. Infection 1995; 23:94-97.
    43) McCalmont C & Zanolli MD: Rickettsial diseases. Dermatol Clin 1989; 7:591-601.
    44) NHLBI ARDS Network: Mechanical ventilation protocol summary. Massachusetts General Hospital. Boston, MA. 2008. Available from URL: http://www.ardsnet.org/system/files/6mlcardsmall_2008update_final_JULY2008.pdf. As accessed 2013-08-07.
    45) Niang M, Brouqui P, & Raoult D: Epidemic typhus imported from Algeria. Emerging Infect Dis 1999; 5(5):1-4.
    46) Norazah A, Mazlah A, & Cheong YM: Laboratory acquired murine typhus - A case report. Med J Malaysia 1995; 50:177-179.
    47) O'Connor LF, Kelly HA, & Lubich JM: A cluster of murine typhus cases in Western Australia. Med J Aust 1996; 165:24-26.
    48) Oh M, Kim N, Huh M, et al: Scrub typhus pneumonitis acquired through the respiratory tract in a laboratory worker. Infection 2001; 29(1):54-56.
    49) Pai H, Sohn S, & Seong Y: Central nervous system involvement in patients with scrub typhus. Clin Infect Dis 1997; 24:436-440.
    50) Peberdy MA , Callaway CW , Neumar RW , et al: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care science. Part 9: post–cardiac arrest care. Circulation 2010; 122(18 Suppl 3):S768-S786.
    51) Perine PL, Chandler BP, & Krause DK: A clinicoepidemiological study of epidemic typhus in Africa. Clin Infect Dis 1992; 14:1149-1158.
    52) Phommasone K, Paris DH, Anantatat T, et al: Concurrent Infection with murine typhus and scrub typhus in southern Laos--the mixed and the unmixed. PLoS Negl Trop Dis 2013; 7(8):e2163.
    53) Product Information: CEREBYX(R) intravenous injection, fosphenytoin sodium intravenous injection. Pfizer Labs (per FDA), New York, NY, 2014.
    54) Product Information: Dilantin(R) intravenous injection, intramuscular injection, phenytoin sodium intravenous injection, intramuscular injection. Parke-Davis (per FDA), New York, NY, 2013.
    55) Product Information: diazepam IM, IV injection, diazepam IM, IV injection. Hospira, Inc (per Manufacturer), Lake Forest, IL, 2008.
    56) Product Information: dopamine hcl, 5% dextrose IV injection, dopamine hcl, 5% dextrose IV injection. Hospira,Inc, Lake Forest, IL, 2004.
    57) Product Information: lorazepam IM, IV injection, lorazepam IM, IV injection. Akorn, Inc, Lake Forest, IL, 2008.
    58) Product Information: norepinephrine bitartrate injection, norepinephrine bitartrate injection. Sicor Pharmaceuticals,Inc, Irvine, CA, 2005.
    59) Raoult D, Ndihokubwayo JB, & Tissot-Dupont H: Outbreak of epidemic typhus associated with trench fever in Burundi. Lancet 1998; 352:353-358.
    60) Raoult D, Roux V, & Ndihokubwayo JB: Jail fever (epidemic typhus) outbreak in Burundi. Emerging Infect Dis 1997; 3:357-360.
    61) Scott R, Besag FMC, & Neville BGR: Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomized trial. Lancet 1999; 353:623-626.
    62) Shaked Y, Shpilberg O, & Samra Y: Involvement of the kidneys in Mediterranean spotted fever and murine typhus. Quarterly J Med 1994; 87:103-107.
    63) Shaked Y: Rickettsial infection of the central nervous system: The role of prompt antimicrobial therapy. Quart J Med, New Series 1991; 79:301-306.
    64) Silpapojakul K, Mitarnun W, & Ocartlarnporn B: Liver involvement in murine typhus. Quarterly J Med 1996; 89:623-629.
    65) Silpapojakul K, Pradutkanchana J, & Pradutkanchana S: Rapid, simple serodiagnosis of murine typhus. Trans Roy Soc Trop Med Hyg 1995; 89:625-628.
    66) Singh PS: An atypical case of typhus fever with toxaemia from eastern zone of Assam (letter). J Assoc Physicians India 1994; 42:427-428.
    67) Sreenath TG, Gupta P, Sharma KK, et al: Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: A randomized controlled trial. Eur J Paediatr Neurol 2009; Epub:Epub.
    68) Stolbach A & Hoffman RS: Respiratory Principles. In: Nelson LS, Hoffman RS, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies, 9th ed. McGraw Hill Medical, New York, NY, 2011.
    69) Strickman D, Tanskul P, & Eamsila C: Prevalence of antibodies to rickettsiae in the human population of suburban Bangkok. Am J Trop Med Hyg 1994; 51:149-153.
    70) Sugita Y, Yamakawa Y, & Takahashi K: A polymerase chain reaction system for rapid diagnosis of scrub typhus within six hours. Am J Trop Med Hyg 1993; 49:636-640.
    71) Suntharasaj T, Janjindamai W, & Krisanapan S: Pregnancy with scrub typhus and vertical transmission: A case report. J Obstet Gynaecol Res 1997; 23:75-78.
    72) Tarasevich I, Rydkina E, & Raoult D: Outbreak of epidemic typhus in Russia (letter). Lancet 1998; 352:1151.
    73) Walker DH, Parks FM, & Betz TG: Histopathology and immunohistologic demonstration of the distribution of Rickettsia typhi in fatal murine typhus. Am J Clin Pathol 1989; 91:720-724.
    74) Walker DH: The role of host factors in the severity of spotted fever and typhus rickettsioses. Ann Acad Sci 1990; 590:10-19.
    75) Wallace KL: Toxin-Induced Seizures. In: Brent J, Wallace KL, Burkhart KK, et al, eds. Critical Care Toxicology, Elsevier Mosby, Philadelphia, PA, 2005.
    76) Watt G & Strickman D: Life-threatening scrub typhus in a traveler from Thailand. Clin Infect Dis 1994; 18:624-626.
    77) Watt G G, Chouriyagune C, & Ruangweerayud R: Scrub typhus infections poorly responsive to antibiotics in northern Thailand. Lancet 1996; 348:86-89.
    78) Wenzel RP, Hayden FG, & Groschel DHM: Acute febrile cerebrovasculitis: A syndrome of unknown, perhaps rickettsial, cause. Ann Intern Med 1986; 104:606-615.
    79) Whiteford SF, Taylor JP, & Dumler JS: Clinical, laboratory, and epidemiologic features of murine typhus in 97 Texas children. Arch Pediatr Adolesc Med 2001; 155(3):396-400.
    80) Willson DF, Truwit JD, Conaway MR, et al: The adult calfactant in acute respiratory distress syndrome (CARDS) trial. Chest 2015; 148(2):356-364.
    81) Wilson DF, Thomas NJ, Markovitz BP, et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury. A randomized controlled trial. JAMA 2005; 293:470-476.
    82) Woodward TE: Rickettsial diseases. In: Isselbacher KJ, Braunwald E, Wilson JD et al (Eds): Harrison's Principles of Internal Medicine, 13'th ed, McGraw-Hill, New York, NY, 1994, pp 747-757.
    83) Yang CH, Hsu GJ, & Peng MY: Hepatic dysfunction in scrub typhus. J Formos Med Assoc 1995a; 94:101-105.
    84) Yang CH, Young TG, & Peng MY: Unusual presentation of acute abdomen in scrub typhus: A report of two cases. Chin Med J (Taipei) 1995; 55:401-404.
    85) Yi KS, Chong Y, & Covington SC: Scrub typhus in Korea: importance of early clinical diagnosis in this newly recognized area. Milit Med 1993; 158:269-273.
    86) Zanetti G, Francioli P, Tagan D, et al: Imported epidemic typhus (letter).. Lancet 1998; 352:1709.